BR9906312A - Método de produção de composto de isoxazolidinadiona - Google Patents
Método de produção de composto de isoxazolidinadionaInfo
- Publication number
- BR9906312A BR9906312A BR9906312-3A BR9906312A BR9906312A BR 9906312 A BR9906312 A BR 9906312A BR 9906312 A BR9906312 A BR 9906312A BR 9906312 A BR9906312 A BR 9906312A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- optionally substituted
- production
- production method
- hydrocarbon group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Patente de Invenção: <B>"MéTODO DE PRODUçãO DE COMPOSTO DE ISOXAZOLIDINADIONA"<D>. A presente invenção refere-se a um novo método para a produção de um composto da fórmula [11] em que R é um grupo hidrocarboneto aromático opcionalmente substituído, um grupo hidrocarboneto alicíclico opcionalmente substituído, um grupo heterocíclico opcionalmente substituído ou um grupo heterocíclico condensado opcionalmente substituído, o qual é útil como agente terapêutico para diabetes. O método da presente invenção é um método industrialmente utilizável que possibilita a produção eficiente do composto alvo [11] a partir de L-aspartato de <225>-metila via um composto intermediário importante [6] em que R é conforme definido acima, em elevado rendimento.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10409898 | 1998-03-30 | ||
| PCT/JP1999/001434 WO1999050267A1 (fr) | 1998-03-30 | 1999-03-19 | Procede permettant de produire un compose a base d'iso-oxazolidinedione |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9906312A true BR9906312A (pt) | 2000-07-11 |
Family
ID=14371652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9906312-3A BR9906312A (pt) | 1998-03-30 | 1999-03-19 | Método de produção de composto de isoxazolidinadiona |
Country Status (25)
| Country | Link |
|---|---|
| US (4) | US6248897B1 (pt) |
| EP (3) | EP1375499A1 (pt) |
| JP (1) | JP2000143596A (pt) |
| KR (1) | KR100321608B1 (pt) |
| CN (4) | CN1130361C (pt) |
| AR (1) | AR015745A1 (pt) |
| AT (1) | ATE258931T1 (pt) |
| AU (1) | AU738200B2 (pt) |
| BR (1) | BR9906312A (pt) |
| CA (1) | CA2291620C (pt) |
| CO (1) | CO5080736A1 (pt) |
| CZ (1) | CZ296507B6 (pt) |
| DE (1) | DE69914557T2 (pt) |
| ES (1) | ES2211053T3 (pt) |
| HU (1) | HUP0003273A3 (pt) |
| IL (1) | IL133146A (pt) |
| NO (4) | NO314403B1 (pt) |
| NZ (1) | NZ501896A (pt) |
| PE (1) | PE20000359A1 (pt) |
| RU (1) | RU2180663C2 (pt) |
| SG (1) | SG73627A1 (pt) |
| SK (1) | SK161499A3 (pt) |
| TW (1) | TWI224594B (pt) |
| WO (1) | WO1999050267A1 (pt) |
| ZA (1) | ZA997705B (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69914557T2 (de) * | 1998-03-30 | 2005-01-05 | Japan Tobacco Inc. | Verfahren zur herstellung einer isooxazolidindion-verbindung |
| US6958355B2 (en) | 2000-04-24 | 2005-10-25 | Aryx Therapeutics, Inc. | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| US6680387B2 (en) | 2000-04-24 | 2004-01-20 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| US6784199B2 (en) | 2000-09-21 | 2004-08-31 | Aryx Therapeutics | Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals |
| US6768008B2 (en) | 2000-04-24 | 2004-07-27 | Aryx Therapeutics | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| CN101519386A (zh) * | 2001-04-16 | 2009-09-02 | 田边三菱制药株式会社 | 高传导率钙-活化k通道开启剂 |
| US6696474B2 (en) * | 2002-04-03 | 2004-02-24 | Warner Lambert Co. Llc. | Antidiabetic agents |
| US6716842B2 (en) * | 2002-04-05 | 2004-04-06 | Warner-Lambert Company, Llc | Antidiabetic agents |
| TWI343915B (en) * | 2002-10-07 | 2011-06-21 | Hoffmann La Roche | Chirale ppar agonists |
| DE10328174A1 (de) * | 2003-06-24 | 2005-01-13 | Bayer Healthcare Ag | Verfahren zur Herstellung von Aryloxazolylethylalkohol |
| CN101146801A (zh) * | 2005-03-22 | 2008-03-19 | 霍夫曼-拉罗奇有限公司 | 新型的dpp-iv抑制剂的盐和多晶型物 |
| EP1892231A1 (en) * | 2006-08-21 | 2008-02-27 | Bayer Schering Pharma Aktiengesellschaft | A large scale method for the deoxofluorination of ketones |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1859667A (en) * | 1930-05-14 | 1932-05-24 | J K Gruner Lumber Company | Jointed lumber |
| JPS58219169A (ja) | 1982-06-15 | 1983-12-20 | Takeda Chem Ind Ltd | オキサゾ−ル酢酸誘導体 |
| CN1003445B (zh) | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物，其制备方法和用途 |
| US5059720A (en) * | 1990-01-31 | 1991-10-22 | E. I. Du Pont De Nemours And Company | Hydroxy containing fluorovinyl compounds and polymers thereof |
| JPH0678326B2 (ja) | 1990-08-23 | 1994-10-05 | フアイザー・インコーポレイテツド | 血糖低下性ヒドロキシ尿素誘導体 |
| CA2075553A1 (en) * | 1992-08-07 | 1994-02-08 | George Zafir | Insulated panel |
| EP0643179B1 (en) * | 1992-12-28 | 1998-12-16 | Ig-Technical Research Inc. | Refractory heat-insulating panel |
| JPH07188227A (ja) | 1993-12-24 | 1995-07-25 | Japan Tobacco Inc | チアゾリジン誘導体及びオキサゾール誘導体 |
| WO1995018125A1 (fr) | 1993-12-27 | 1995-07-06 | Japan Tobacco Inc. | Derive d'isoxazolidinedione et son utilisation |
| TW403748B (en) * | 1994-11-02 | 2000-09-01 | Takeda Chemical Industries Ltd | An oxazolidinedione derivative, its production and a pharmaceutical composition for lowering blood sugar and lipid in blood comprising the same |
| NZ314406A (en) * | 1996-03-18 | 2000-12-22 | Sankyo Co | Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles |
| US5768850A (en) * | 1997-02-04 | 1998-06-23 | Chen; Alen | Method for erecting floor boards and a board assembly using the method |
| DE69914557T2 (de) * | 1998-03-30 | 2005-01-05 | Japan Tobacco Inc. | Verfahren zur herstellung einer isooxazolidindion-verbindung |
| DE19851200C1 (de) * | 1998-11-06 | 2000-03-30 | Kronotex Gmbh Holz Und Kunstha | Fußbodenpaneele |
| US8234204B2 (en) * | 2000-11-13 | 2012-07-31 | Goldman, Sachs & Co. | Method and system for matching short trading positions with long trading positions |
-
1999
- 1999-03-19 DE DE69914557T patent/DE69914557T2/de not_active Expired - Fee Related
- 1999-03-19 SK SK1614-99A patent/SK161499A3/sk unknown
- 1999-03-19 HU HU0003273A patent/HUP0003273A3/hu unknown
- 1999-03-19 NZ NZ501896A patent/NZ501896A/xx unknown
- 1999-03-19 ES ES99909293T patent/ES2211053T3/es not_active Expired - Lifetime
- 1999-03-19 US US09/424,711 patent/US6248897B1/en not_active Expired - Fee Related
- 1999-03-19 EP EP03020537A patent/EP1375499A1/en not_active Withdrawn
- 1999-03-19 CN CN99800858A patent/CN1130361C/zh not_active Expired - Fee Related
- 1999-03-19 KR KR1019997011020A patent/KR100321608B1/ko not_active IP Right Cessation
- 1999-03-19 AT AT99909293T patent/ATE258931T1/de not_active IP Right Cessation
- 1999-03-19 CN CNB2003101013392A patent/CN1235887C/zh not_active Expired - Fee Related
- 1999-03-19 RU RU99128102/04A patent/RU2180663C2/ru not_active IP Right Cessation
- 1999-03-19 CA CA002291620A patent/CA2291620C/en not_active Expired - Fee Related
- 1999-03-19 CZ CZ0422499A patent/CZ296507B6/cs not_active IP Right Cessation
- 1999-03-19 EP EP03020538A patent/EP1384722A1/en not_active Withdrawn
- 1999-03-19 BR BR9906312-3A patent/BR9906312A/pt not_active IP Right Cessation
- 1999-03-19 EP EP99909293A patent/EP0992503B1/en not_active Expired - Lifetime
- 1999-03-19 AU AU28548/99A patent/AU738200B2/en not_active Ceased
- 1999-03-19 WO PCT/JP1999/001434 patent/WO1999050267A1/ja active IP Right Grant
- 1999-03-19 IL IL13314699A patent/IL133146A/en not_active IP Right Cessation
- 1999-03-19 CN CNB2003101013405A patent/CN1232511C/zh not_active Expired - Fee Related
- 1999-03-19 CN CNA2005101200256A patent/CN1781915A/zh active Pending
- 1999-03-26 TW TW088104758A patent/TWI224594B/zh not_active IP Right Cessation
- 1999-03-30 PE PE1999000258A patent/PE20000359A1/es not_active Application Discontinuation
- 1999-03-30 AR ARP990101416A patent/AR015745A1/es not_active Application Discontinuation
- 1999-03-30 CO CO99019141A patent/CO5080736A1/es unknown
- 1999-03-30 SG SG1999001563A patent/SG73627A1/en unknown
- 1999-11-29 NO NO19995851A patent/NO314403B1/no not_active IP Right Cessation
- 1999-12-15 ZA ZA9907705A patent/ZA997705B/xx unknown
- 1999-12-20 JP JP11360189A patent/JP2000143596A/ja active Pending
-
2001
- 2001-04-23 US US09/839,215 patent/US6444827B2/en not_active Expired - Fee Related
-
2002
- 2002-07-19 US US10/198,171 patent/US6699996B2/en not_active Expired - Fee Related
- 2002-08-26 NO NO20024060A patent/NO315199B1/no not_active IP Right Cessation
- 2002-08-26 NO NO20024058A patent/NO315198B1/no not_active IP Right Cessation
- 2002-08-26 NO NO20024059A patent/NO315197B1/no not_active IP Right Cessation
-
2003
- 2003-09-30 US US10/673,512 patent/US6995271B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9906312A (pt) | Método de produção de composto de isoxazolidinadiona | |
| BR0310106A (pt) | Composto, processo para a produção de um composto, composição farmacêutica, uso do composto e método para o tratamento de um sujeito em sofrimento de uma condição ou doença patalógica | |
| BR0209129A (pt) | Compostos, composições farmacêuticas, métodos para tratamento de dores, métodos para modulação de uma resposta farmacológica e usos de compostos | |
| EA201101308A1 (ru) | Применение ралфинамида для лечения биполярного расстройства | |
| BR0211169A (pt) | Processo para preparação de derivados de amidina | |
| DE60012751D1 (de) | Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz | |
| BR0311783A (pt) | Palatinose condensada e método para produzir a mesma | |
| BRPI0411285A (pt) | composto, processo para preparar um composto formulação farmacêutica, uso de um composto, e, método de prevenção ou tratamento de distúrbios | |
| BRPI0416228A (pt) | uso de inibidores glucosidade para terapia de mucovisidose | |
| BR0014808A (pt) | Processos de preparação de um composto, e, compostos nitroaromáticos | |
| BR0007784A (pt) | Composto, método para inibir mudanças patológicas mediadas pela enzima que converte o tnf-alfa (tace) em um mamìfero, composição farmacêutica, e, processo para preparar um composto | |
| IE56543B1 (en) | Process for preparing 4-amino-5-hexenoic acid | |
| BR0309753A (pt) | Processo para a preparação de derivados de 6-alquilideno penem | |
| NO20014241D0 (no) | C16-umettede FP-selektive prostaglandinanaloger | |
| BR0008778A (pt) | Análogos de prostaglandinas seletivos para fpc16 insaturados | |
| BR9912556A (pt) | Triazolpiridinas para o tratamento de distúrbios trombóticos | |
| BR9911559A (pt) | Processo para a preparação de um composto, composto, processo para o tratamento de tumores resistentes a medicamento múltiplo, uso de um composto, e, agente e composição para tratar tumores resistentes a medicamento múltiplo. | |
| CN101166718A (zh) | 雄性激素调节剂 | |
| BR0012631A (pt) | Processo para a preparação de compostos de amina | |
| BRPI0415109A (pt) | compostos de 1-[2-(4-hidroxifenil)-2-hidroxietil]-piperidin-4-ol como antagonistas de receptor de nmda | |
| BRPI0812919B1 (pt) | composição farmacêutica que compreende um composto e kit | |
| ATE267832T1 (de) | Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung | |
| BR9814161A (pt) | Método de sìntese de pirrolamidas | |
| BR0004965A (pt) | Processo para preparação de compostos de cromano esterificados | |
| BR0013094A (pt) | Processo para a preparação de compostos 1,3-dicarbonìlicos acilados |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008. |